genprowebdirectory
GEN Edge
News
Insights
Trends for 2020
A-Lists
Topics
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
Magazine
Resources
GEN Live
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
Subscribe
Create a Free Account
Get GEN Edge
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Search
Advertising
Magazine Advertising
Website Banner Advertising
eNewsletter Advertising
Webinar Sponsorship
eBook Advertising
Email Nurture Campaigns
Ad Terms and Conditions
About GEN
Contact GEN
Create a Free Account
Get GEN Edge
Log In
GEN – Genetic Engineering and Biotechnology News
Mary Ann Liebert, Inc. Publishers
GEN Edge
Big Data
A Unicorn Rivalry Shaping the Future of the Synbio Industry
Gene Therapy
At Orchard, Moving from Pruning to Planting
GEN Edge
Massachusetts Biopharma Industry Weathers COVID-19 Impacts on Jobs, Financing
AAV (Adeno-associated virus)
Quartet of COVID-19 Vaccine Candidates Head toward the Homestretch
Coronavirus
Rough Surf Ahead for California
News
Cancer
Researchers Find a Gene Mutation in Tasmanian Devil Cancer That May…
Epigenetics
DNA Methylation Sites IDed by Machine Learning Algorithm
Autism
Autism-Related Social Behaviors in Mice Tied to Gene Mutation, and Normalized…
News
Enzyme Identified that May Provide Novel Therapeutic Approach to Huntington’s
Cancer
Epigenetic Regulation Key to Daily Formation of Billions of Blood Cells
Insights
All
Trends for 2020
Bioprocessing
Remote Control of CAR T Cells to Enhance Safety
Bioprocessing
Standardizing Cell and Gene Therapy Remains Bioindustry Goal
Bioprocessing
COVID-19 Increases Demand for Next-Generation Bioprocessing Technology
Bioprocessing
Moving Quickly but Smartly from R&D to Commercialization
A-Lists
July 2020 Vol. 40 No. 7
Top 10 Earners among Women Biopharma Executives
June 2020 Vol. 40 No. 6
In Praise of Lesser-Sung Life Sciences Clusters
Coronavirus
Blinking Red: 25 Missed Pandemic Warning Signs
Coronavirus
Vanquishing the Virus: 160+ COVID-19 Drug and Vaccine Candidates in Development
Coronavirus
Catching Up to Coronavirus: Top 60 Treatments in Development
Topics
All
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
Cancer
Researchers Find a Gene Mutation in Tasmanian Devil Cancer That May…
Epigenetics
DNA Methylation Sites IDed by Machine Learning Algorithm
Autism
Autism-Related Social Behaviors in Mice Tied to Gene Mutation, and Normalized…
Cancer
Epigenetic Regulation Key to Daily Formation of Billions of Blood Cells
Magazine
July 2020 Vol. 40 No. 7
Rosalind Franklin the Scientist
July 2020 Vol. 40 No. 7
COVID-19 Research: Women Are Changing the Face of the Pandemic
July 2020 Vol. 40 No. 7
CRISPR Screening Explores New Dimensions
July 2020 Vol. 40 No. 7
Top 10 Earners among Women Biopharma Executives
Commentary
Clues to Healthier Aging in Cellular Senescence
Resources
All
GEN Live
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
Tutorial
In-Depth GPCR Signaling Characterization for Improved Drug Discovery
New Products
Precoated Plates
New Products
Liquid Chromatograph Mass Spectrometer
New Products
RNA Quantification Assay
Subscribe
Create a Free Account
Get GEN Edge
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Home
Companies
shire
shire
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
shire
Shire, Takeda Shareholders Approve $58.5B Acquisition Deal
shire
Shire Licenses Rare Liver Disease Candidates to $120M Startup Mirum
shire
Sanofi Pasteur, Translate Bio Launch mRNA Vaccine Partnership
shire
Shire, Takeda Come to Terms on $62B Acquisition Deal
shire
Shire Board Sets Stage for $64B Takeda Acquisition, If Companies Resolve Details
shire
Shire Rejects Takeda Takeover Bids
shire
Servier to Acquire Shire’s Oncology Business for $2.4B
shire
Shire Pursues FDA Approval for Plasma Manufacturing Facility
shire
Lonza Expands in Mammalian Manufacturing with Purchase of California Site
shire
Shire Transfers IND for GvHD Candidate to Kamada
shire
Shire Hemophilia Candidate Using Xenetic Platform Falls Short in Trial
shire
Shire Plans Lanadelumab BLA Submission Following Positive Phase III HAE Results
shire
Shire, Parion Ink Deal for Up to $535M to Develop Phase...
shire
EC Approves Shire’s Recombinant Parathyroid Hormone for Hypoparathyroidism
shire
RaNA Therapeutics Acquires Shire’s mRNA Platform
Load more
Scroll Up
Please wait while you are redirected to the right page...
We use cookies to give you a better experience on genengnews.com. By continuing to use our site, you are agreeing to the use of cookies as set in our
privacy policy.
Got it!
Edit with Live CSS
/* The alert message box */ .alert { padding: 20px; background-color: #ff9800; /* Red */ color: white; margin-bottom: 15px; } /* The close button */ .closebtn { margin-left: 15px; color: white; font-weight: bold; float: right; font-size: 22px; line-height: 20px; cursor: pointer; transition: 0.3s; } /* When moving the mouse over the close button */ .closebtn:hover { color: black; } .td_module_flex_2 .entry-title { font-size: 17px; line-height: 20px; }
![Sanofi’s global vaccines unit Sanofi Pasteur has launched an up-to-$805 million partnership with Translate Bio to develop messenger RNA vaccines for up to five undisclosed infectious disease pathogens. [Ryan Jeffs/Wikicommons]](https://www.genengnews.com/wp-content/uploads/2018/08/Mar14_2017_WikiCommons_MicroRNAAndmRNAVisualization2173942127-265x198.jpg "Sanofi Pasteur, Translate Bio Launch mRNA Vaccine Partnership")
